Dong-E-E-Jiao Co Ltd
SZSE:000423
Dong-E-E-Jiao Co Ltd
Net Income (Common)
Dong-E-E-Jiao Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dong-E-E-Jiao Co Ltd
SZSE:000423
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
198%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥755.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Dong-E-E-Jiao Co Ltd's Net Income (Common)?
Net Income (Common)
1.2B
CNY
Based on the financial report for Dec 31, 2023, Dong-E-E-Jiao Co Ltd's Net Income (Common) amounts to 1.2B CNY.
What is Dong-E-E-Jiao Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
0%
Over the last year, the Net Income (Common) growth was 48%. The average annual Net Income (Common) growth rates for Dong-E-E-Jiao Co Ltd have been 198% over the past three years , -11% over the past five years .